+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genomic Biomarker Market - Global Forecast 2026-2032- Product Image
Genomic Biomarker Market - Global Forecast 2026-2032- Product Image
New

Genomic Biomarker Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977839
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genomic biomarker market is undergoing a transformation, propelled by deepening integration of advanced technologies, evolving regulatory frameworks, and the pressing need for clinical-grade, reproducible results. Senior leaders must navigate this complex environment to convert breakthroughs into sustained growth and scalable value.

Market Snapshot: Genomic Biomarker Market Growth

The Genomic Biomarker Market expanded from USD 4.99 billion in 2025 to USD 5.31 billion in 2026. It is projected to maintain momentum with a CAGR of 6.96%, reaching USD 8.00 billion by 2032. This sustained growth underscores a robust ecosystem with increasing relevance across clinical, diagnostic, and R&D sectors.

Scope & Segmentation: Genomic Biomarker Market

  • Product Categories: Instruments (mass spectrometry, microarray, PCR, sequencers), reagents and kits, and service offerings including bioinformatics and sequencing services.
  • Core Technologies: Next-generation sequencing, mass spectrometry (GC-MS, LC-MS/MS, MALDI-TOF), digital and quantitative PCR, microarray platforms.
  • Applications: Diagnostics (genetic testing, oncology, pharmacogenomics), drug discovery and development, personalized medicine (companion diagnostics, predictive biomarkers), and basic to translational research.
  • End Users: Academic and research institutes, contract research organizations, hospitals and diagnostic laboratories, pharmaceutical and biotech companies.
  • Biomarker Types: DNA (copy number, mutations), epigenetic (chromatin accessibility, methylation), protein (proteomics, phosphoproteomics), and RNA (lncRNA, miRNA, mRNA).
  • Geographical Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with distinct regulatory, supply chain, and adoption profiles.

Key Takeaways for Senior Decision-Makers

  • Technological convergence, including modular platforms and expanded automation, is driving sharper clinical and translational outcomes.
  • Stakeholders must balance innovation with reproducibility, standardization, and regulatory requirements to accelerate clinical adoption.
  • Segmented end-user demands necessitate adaptable service models and in-depth data integration, supporting personalized medicine and real-world evidence generation.
  • Strategic alignment between instrument providers, reagent suppliers, and informatics firms enhances value through interoperability and robust validation pathways.
  • Market competitiveness increasingly relies on operational agility, cross-disciplinary partnerships, and proven clinical utility of biomarker solutions.

Tariff Impact: U.S. 2025 Measures on Supply Chains and Procurement

The 2025 U.S. tariff measures have introduced new cost structures and extended procurement timelines for instruments and reagents. Laboratories, especially those with limited budgets, are adopting alternative approaches—such as leasing or service contracts—to sustain operations. Suppliers are adjusting by localizing manufacturing or diversifying outsourcing, while stakeholders are reinforcing supply resilience through multi-vendor qualification and negotiated contracts. Regulatory and administrative complexities have increased, affecting cross-border services and adding to project lead times. Organizations leveraging cloud-enabled analytics and remote service models partially mitigate these trade- and customs-related pressures, fostering flexibility amid ongoing sourcing disruptions.

Methodology & Data Sources

This report employs rigorous analysis, combining primary interviews with laboratory and R&D leaders, input from regulatory and reimbursement experts, and secondary review of peer-reviewed publications and technical benchmarks. Qualitative and scenario-based methods clarify both market direction and stakeholder challenges. All findings are supported by reproducible protocols and independent data validation to ensure reliable, evidence-based guidance.

Why This Report Matters

  • Empowers leadership to anticipate shifting market forces and proactively align operational strategies for sustained growth.
  • Clarifies where investment in technology, partnerships, and supply chains can deliver competitive advantage and clinical impact.
  • Distills regional nuance and practical segmentation to guide commercialization and go-to-market strategy across global geographies.

Conclusion

The genomic biomarker market presents layered strategic opportunities shaped by aligned innovation, regulatory readiness, and regional operational dynamics. Leaders positioned to convert scientific advances into real-world diagnostics and personalized care will shape the next phase of market maturity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Genomic Biomarker Market, by Product Type
8.1. Instruments
8.1.1. Mass Spectrometry Systems
8.1.2. Microarray Systems
8.1.2.1. Gene Expression Arrays
8.1.2.2. Protein Arrays
8.1.2.3. Snp Arrays
8.1.3. Pcr Systems
8.1.3.1. Digital PCR
8.1.3.2. qPCR
8.1.3.3. Rt-PCR
8.1.4. Sequencers
8.1.4.1. Next-Generation Sequencers
8.1.4.2. Sanger Sequencers
8.2. Reagents & Kits
8.2.1. Consumables
8.2.1.1. Enzymes
8.2.1.2. Probes & Primers
8.2.2. Kits
8.2.2.1. Library Prep Kits
8.2.2.2. Microarray Kits
8.2.2.3. Pcr Kits
8.3. Services
8.3.1. Bioinformatics Services
8.3.2. Custom Assay Development
8.3.3. Data Analysis Services
8.3.4. Sequencing Services
8.3.4.1. Exome Sequencing
8.3.4.2. RNA Sequencing
8.3.4.3. Targeted Sequencing
8.3.4.4. Whole Genome Sequencing
9. Genomic Biomarker Market, by Application
9.1. Diagnostics
9.1.1. Genetic Testing
9.1.2. Infectious Disease Testing
9.1.3. Oncology Diagnostics
9.1.4. Pharmacogenomic Testing
9.2. Drug Discovery & Development
9.2.1. Lead Optimization
9.2.2. Screening
9.2.3. Target Identification
9.2.4. Target Validation
9.3. Personalized Medicine
9.3.1. Companion Diagnostics
9.3.2. Predictive Biomarkers
9.3.3. Stratified Medicine
9.4. Research
9.4.1. Basic Research
9.4.2. Clinical Research
9.4.3. Translational Research
10. Genomic Biomarker Market, by End User
10.1. Academic & Research Institutes
10.2. Contract Research Organizations
10.3. Hospitals & Diagnostic Laboratories
10.4. Pharmaceutical & Biotechnology Companies
11. Genomic Biomarker Market, by Biomarker Type
11.1. DNA
11.1.1. Copy Number Variation
11.1.2. Methylation
11.1.3. Point Mutations
11.1.4. Structural Variations
11.2. Epigenetic
11.2.1. Chromatin Accessibility
11.2.2. DNA Methylation
11.2.3. Histone Modification
11.3. Protein
11.3.1. Phosphoproteomics
11.3.2. Proteomics
11.4. RNA
11.4.1. Lncrna
11.4.2. miRNA
11.4.3. mRNA
12. Genomic Biomarker Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Genomic Biomarker Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Genomic Biomarker Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Genomic Biomarker Market
16. China Genomic Biomarker Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Agilent Technologies, Inc.
17.7. APIS Assay Technologies Limited
17.8. Augurex Life Sciences Corp
17.9. Bio-Rad Laboratories, Inc.
17.10. Bio-Techne Corporation
17.11. Biocrates Life Sciences AG
17.12. Biostarks Laboratories SA
17.13. Bruker Corporation
17.14. CD Genomics
17.15. Charles River Laboratories, Inc.
17.16. DH Life Sciences, LLC.
17.17. Elo Health, Inc.
17.18. Eurofins Scientific corporation
17.19. F. Hoffmann-La Roche Ltd
17.20. Illumina Inc.
17.21. Merck KGaA
17.22. Myriad Genetics, Inc
17.23. Owkin, Inc
17.24. Thermo Fisher Scientific company
List of Figures
FIGURE 1. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENOMIC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENOMIC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GENOMIC BIOMARKER MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 230. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 231. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 232. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 233. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 234. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 235. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 236. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 237. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 238. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2032 (USD MILLION)
TABLE 239. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 242. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 243. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 244. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 246. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 247. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2032 (USD MILLION)
TABLE 248. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 249. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 253. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 254. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 255. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 256. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 257. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 258. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 259. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 260. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2032 (USD MILLION)
TABLE 261. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 263. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 264. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 265. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 266. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 268. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 269. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2032 (USD MILLION)
TABLE 270. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 271. NORTH AMERICA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 282. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2032 (USD MILLION)
TABLE 283. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 285. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 286. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 287. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 288. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 290. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 291. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2032 (USD MILLION)
TABLE 292. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 293. LATIN AMERICA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2032 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2032 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 316. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 317. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 318. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 319. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2032 (USD MILLION)
TABLE 320. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 321. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2032 (USD MILLION)
TABLE 322. EUROPE GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 323. EUROPE GENOMIC BIOMARKER

Companies Mentioned

The key companies profiled in this Genomic Biomarker market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • APIS Assay Technologies Limited
  • Augurex Life Sciences Corp
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biocrates Life Sciences AG
  • Biostarks Laboratories SA
  • Bruker Corporation
  • CD Genomics
  • Charles River Laboratories, Inc.
  • DH Life Sciences, LLC.
  • Elo Health, Inc.
  • Eurofins Scientific corporation
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • Merck KGaA
  • Myriad Genetics, Inc
  • Owkin, Inc
  • Thermo Fisher Scientific company

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 8 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Genomic Biomarker Market Report 2025 - Product Image

Genomic Biomarker Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Genomics Market - Global Forecast 2026-2032 - Product Image

Genomics Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Genomic and Proteomic Tool Market Report 2025 - Product Image

Genomic and Proteomic Tool Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Biomarker Testing Services Market - Global Forecast 2026-2032 - Product Image

Biomarker Testing Services Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Genomics Market Report and Forecast 2025-2034 - Product Image

Genomics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Genomic Biomarker Market

Genomic biomarkers are a type of biomarker that are used to identify and measure genetic material in a biological sample. They are used to detect genetic variations that can be used to diagnose and monitor diseases, predict drug response, and identify individuals at risk for certain conditions. Genomic biomarkers are used in a variety of applications, including personalized medicine, drug development, and diagnostics. Genomic biomarkers are typically identified through the analysis of DNA, RNA, and proteins. They can be used to detect genetic variations that are associated with diseases, such as cancer, and to identify individuals at risk for certain conditions. Genomic biomarkers can also be used to predict drug response and to monitor the progression of diseases. The genomic biomarker market is expected to grow significantly in the coming years, driven by advances in technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.